Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis - — JAMA
Links shared publicly online about this topic.
- 0total visits
Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis - — JAMA
View full resource at jama.ama-assn.org
Tags: Arthritis, Rheumatoid Arthritis Medication, Juvenile Rheumatoid Arthritis, Drug, Children's Health, Enbrel
Most Recently Shared on November 6, 2011 at 10:51 pm By:
From #ACR2011 JAMA Online Study: medication for treatment of #juvenilearthritis: http://t.co/B3I9CmkD
Juvenile Arthritis - Factors Linked To Better Medication Response | HEADLINE NEWS ONLINE | LATEST NEWS AND ARTICLES FROM ALL OVER THE WORLD | HEADLINE NEWS
headlinenewsonline.com — “According to JAMA, one third of patients with juvenile idiopathic arthritis (JIA) starting receiving etanercept treatment demonstrated excellent responses. Etanercept, approved 10 years ago by the U.S. FDA and European Agency for the treatment of JIA, is linked to younger age at the onset of JIA, low measures of disability at study entry and fewer disease-modifying antirheumatic drug use before starting etanercept therapy. The study will be presented at the American College of Rheumatology/Assoc” View full resource at headlinenewsonline.com
Most Recently Shared on November 9, 2011 at 7:37 pm By:
Factors linked to better medication response for Juvenile Arthritis http://t.co/wyk2AQQ0
Juvenile Arthritis - Factors Linked To Better Medication Response
medicalnewstoday.com — “According to JAMA, one third of patients with juvenile idiopathic arthritis (JIA) starting receiving etanercept treatment demonstrated excellent responses. Etanercept, approved 10 years ago” View full resource at medicalnewstoday.com
Most Recently Shared on November 8, 2011 at 6:05 pm By:
Juvenile Arthritis - Factors Linked To Better Medication Response http://t.co/MtnQ1pif #arthritis
Advertisement

